Evidence map›Paper›PMID 33293369›Full record

ArticleThe Journal of biological chemistry

Site specificity determinants for prelamin A cleavage by the zinc metalloprotease ZMPSTE24.

Timothy D Babatz, Eric D Spear, Wenxin Xu, Olivia L Sun, Laiyin Nie, Elisabeth P Carpenter, Susan Michaelis

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Abolishing the prelamin A ZMPSTE24 cleavage site leads to progeroid phenotypes with near-normal longevity in mice.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Timothy D BabatzDepartment of Cell Biology, The Johns Hopkins School of Medicine, Baltimore Maryland, USA.
Eric D SpearDepartment of Cell Biology, The Johns Hopkins School of Medicine, Baltimore Maryland, USA.
Wenxin XuDepartment of Cell Biology, The Johns Hopkins School of Medicine, Baltimore Maryland, USA.
Olivia L SunDepartment of Cell Biology, The Johns Hopkins School of Medicine, Baltimore Maryland, USA.
Laiyin NieStructural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Oxford, UK.
Elisabeth P CarpenterStructural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Oxford, UK.
Susan MichaelisDepartment of Cell Biology, The Johns Hopkins School of Medicine, Baltimore Maryland, USA. Electronic address: michaelis@jhmi.edu.
Johns Hopkins University · USUniversity of Oxford · GB

Funding

The integral membrane protease ZMPSTE24, lamin A processing, and the premature aging disease progeriaR35GM127073 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Susan D. Michaelis · 2018 to 2026
$4.4M
Medical Research Council MR/L017458/1NIGMS NIH HHS R35 GM127073Wellcome TrustWellcome Trust 106169/Z/14/Z
6 · The paper itself

Abstract

The integral membrane zinc metalloprotease ZMPSTE24 is important for human health and longevity. ZMPSTE24 performs a key proteolytic step in maturation of prelamin A, the farnesylated precursor of the nuclear scaffold protein lamin A. Mutations in the genes encoding either prelamin A or ZMPSTE24 that prevent cleavage cause the premature aging disease Hutchinson-Gilford progeria syndrome (HGPS) and related progeroid disorders. ZMPSTE24 has a novel structure, with seven transmembrane spans that form a large water-filled membrane chamber whose catalytic site faces the chamber interior. Prelamin A is the only known mammalian substrate for ZMPSTE24; however, the basis of this specificity remains unclear. To define the sequence requirements for ZMPSTE24 cleavage, we mutagenized the eight residues flanking the prelamin A scissile bond (TRSY↓LLGN) to all other 19 amino acids, creating a library of 152 variants. We also replaced these eight residues with sequences derived from putative ZMPSTE24 cleavage sites from amphibian, bird, and fish prelamin A. Cleavage of prelamin A variants was assessed using an in vivo yeast assay that provides a sensitive measure of ZMPSTE24 processing efficiency. We found that residues on the C-terminal side of the cleavage site are most sensitive to changes. Consistent with other zinc metalloproteases, including thermolysin, ZMPSTE24 preferred hydrophobic residues at the P1' position (Leu647), but in addition, showed a similar, albeit muted, pattern at P2'. Our findings begin to define a consensus sequence for ZMPSTE24 that helps to clarify how this physiologically important protease functions and may ultimately lead to identifying additional substrates.

Indexed as

Amino Acid SequenceCatalytic DomainHumansLamin Type AMembrane ProteinsMetalloendopeptidasesMutationProteolysisRecombinant ProteinsSubstrate SpecificityZincLamin Type AMembrane ProteinsMetalloendopeptidasesprelamin ARecombinant ProteinsZincZMPSTE24 protein, humanCAAX motiffarnesylationintramembrane proteolysislamin ALMNAprogeriaproteasesubstrate specificity

Identifiers

PMID33293369
PMCPMC7948416
OpenAlexW3113024278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.